Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability

Current Drug Safety

Volumn 6, Issue 4, 2011, Pages 209-218

  Verster, Joris C ^a   Warren Spence, D ^b   Shahid, Azmeh ^c,d   Pandi Perumal, Seithikurippu R ^e   Roth, Thomas ^f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Toronto Western Hospital ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Youthdale Treatment Centers   (Canada)

^e SOMNOGEN CANADA INC   (Canada)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Active control; Clinical trials; Comparator; Driving; SDLP; Zopiclone

Indexed keywords

ALCOHOL; PLACEBO; ZOPICLONE;

ALCOHOL BLOOD LEVEL; BEDTIME DOSAGE; BREATHING; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRIVING ABILITY; DRUG DOSE COMPARISON; EFFECT SIZE; EMBASE; FUNCTIONAL DISEASE; HUMAN; INSOMNIA; LEARNING TEST; MEASUREMENT; MEDLINE; META ANALYSIS; NETHERLANDS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; REACTION TIME; RECOGNITION; RESIDUE ANALYSIS; REVIEW; SIMULATION; SLEEP THERAPY; SYSTEMATIC REVIEW; TASK PERFORMANCE; TRAFFIC; VELOCITY;

EID: 83455210541     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488611798280933     Document Type: Review

References (70)

1. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004, 8: 309-25.
2. Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 2006, 1: 63-72.
3. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003, 26: 261-82.
4. Paul MA, Gray G, MacLellan M, Pigeau RA. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. Aviat Space Environ Med 2004, 75: 512-519.
5. Vermeeren A, O'Hanlon JF, DeClerck AC, Kho L. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther 1995; 21: 47-64.
6. Vermeeren A, Danjou PE, O'Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol 1998; 13(Suppl 2): S98-S107.
7. Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 2002; 25: 224-31.
8. Verster JC, Volkerts ER, Schreuder AHCML, et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performance. J Clin Psychopharmacol 2002; 22: 576-83.
9. O'Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB. Diazepam impairs lateral position control in highway driving. Science 1982; 217: 79-81.
10. Verster JC, Roth T. Standard Operation Procedures for conducting the on-the-road driving test, and measurement of the Standard Deviation of Lateral Position (SDLP). Int J Gen Med 2011; 4: 359-71.
11. Verster JC, Roth T. Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality. Psychopharmacology 2011 [Epub ahead of print].
12. Verster JC, Roth T. The relation between psychometric tests that measure driving related skills and actual driving performance. Psychopharmacology 2011, in revisions
13. Louwerens JW, Gloerich ABM, De Vries G, Brookhuis KA, O'Hanlon JF. In: Noordzij PC, Roszbach R Eds, The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. Alcohol, Drugs and Traffic Safety. Amsterdam, Excerpta Medica. 1987; pp. 183-192.
14. Mattila ME, Mattila MJ, Nuotto E. Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects. Pharmacol Toxicol 1992; 70: 286-89.
15. Mattila MJ, Vanakoski J, Mattila-Evenden ME, Karonen S-L. Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. Eur J Clin Pharmacol 1994; 46: 215-20.
16. Mattila MJ, Mattila-Evenden ME. Effects of alcohol and hypnosedative drugs on digit-symbol substitution: comparison of two different computerized tests. J Psychopharmacol 1997; 11: 313-17.
17. Mattila MJ, Vanakoski J, Kalska H, Seppälä. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav 1998; 59: 917-23.
18. Saano V, Hansen PP, Paronen P. Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacol Toxicol 1992; 70: 135-39.
19. Kuitunen T, Mattila MJ, Seppälä T, Aranko K, Mattila ME. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol 1990; 30: 453-61.
20. Kuitunen T, Mattila MJ, Seppälä T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol 1990; 5(supplement): 115-30.
21. Aantaa R, Salonen M, Nyrke T. Difference in action between oral triazolam and zopiclone. Eur J Clin Pharmacol 1990, 38: 47-51.
22. Gorenstein C, Tavares SM, Gentil V, Peres C, Moreno RA, Dreyfus JF. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations. Braz J Med Biol Res 1990; 23: 941-51.
23. Warot D, Bensimon G, Danjou P, Puech AJ. Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundam Clin Pharmacol 1987; 1: 145-52.
24. Griffiths AN, Jones DM, Richens A. Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam. Br J Clin Pharmacol 1986; 21: 647-53.
25. Channer KS, Dent M, Roberts CJC. The effects of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone. Br J Clin Pharmacol 1984; 18: 879-86.
26. Parker G, Roberts CJC. Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease. Br J Clin Pharmacol 1983; 16: 259-65.
27. Allain H, Patat A, Lieury A, le Coz F, Janus C, Menard G, Gandon JM. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry 1995; 10(Suppl 3): 129s-35s.
28. Allain H, Bentué-Ferrer D, Tarral A, Gandon J-M. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol 2003; 59: 179-88.
29. Moon CA, Hindmarch I, Holland RL. The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. Int Clin Psychopharmacol 1990; 5(suppl): 79-83.
30. Wickstrøm E, Gotlibsen OB, Bredesen JE, Jensen MH. Performance and mood following partial sleep deprivation: a randomized, double-blind, cross-over study of zopiclone, triazolam, flunitrazepam, ethanol and placebo. Hum Psychopharmacol 1988; 3: 3-11.
31. Stone BM, Turner C, Mills SL, Paty I, Patat A, Darwish M, Danjou P. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. Br J Clin Pharmacol 2002; 53: 196-02.
32. Seppälä T, Nuotto E, Dreyfus JF. Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Pharmacology 1983; 27(supplement 2): 127-135.
33. Hindmarch I. Immediate and overnight effects of zopiclone 7.5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers. Int Clin Psychopharmacol 1990; 5(suppl): 105-13.
34. Borenstein M, Rothstein H. Comprehensive Meta-analysis. A computer program for research synthesis. Biostat, Inc. USA, 1999.
35. Lipsey MW, Wilson DB. Practical meta-analysis. Applied Social Research Methods Series, Sage Publications, Inc. 2001; Vol. 49.
36. Volkerts ER, Louwerens JW, Gloerich ABM, Brookhuis KA, O'Hanlon JF. Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. Traffic Research Centre, Groningen, The Netherlands. Report VK 84-10. 1985.
37. Mets MAJ, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, Verster JC. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance and mood in healthy adult subjects. Sleep 2011; 34: 1327-34.
38. Ramaekers JG, Conen S, de Kam PJ, Braat S, Peeters P, Theunissen EL, Ivgy-May N. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype. Psychopharmacology 2011; 215: 321-32.
39. Leufkens TR, Lund JS, Vermeeren A. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 2009; 18: 398-96.
40. Leufkens TR, Vermeeren A. Highway driving in the elderly the morning after bedtime use of hypnotics. J Clin Psychopharmacol 2009; 29: 432-38.
41. Leufkens TR, Ramaekers JG, de Weerd AW, Riedel WJ, Vermeeren A. Residual effects of zopiclone 7.5 mg on highway driving performance in elderly insomnia patients: a placebo controlled crossover study. In: Leufkens TR. Hypnotics and anxiolytics: field laboratory measures of drug safety in driving performance and cognitive functioning. Thesis. Maastricht, The Netherlands, 2009.
42. Bocca ML, le Doze F, Etard O, Pottier M. Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacol 1999; 143: 373-79.
43. Berthelon C, Bocca ML, Denise P, Pottier A. Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation? J Psychopharmacol 2003; 17: 324-31.
44. Staner L, Ertle S, Boeijinga P, Rinaudo G, Arnal MA, Muzet A, Luthringer R. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology 2005; 181: 790-98.
45. Meskali M, Berthelon C, Marie S, Denise P, Bocca M-L. Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study. Psychopharmacology 2009; 207: 461-67.
46. Bocca ML, Marie S, Lelong-Boulouard V, et al. Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. Psychopharmacology 2011; 214: 699-706.
47. Harrison C, Subhan Z, Hindmarch I. Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs Exp Clin Res 1985; 11: 823-29.
48. Lader M, Denney SC. A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers. Pharmacol 1983; 27(suppl 2): 98-108.
49. Nicholson AN, Stone BM. Zopiclone: sleep and performance studies in healthy man. Pharmacology 1983, 27(suppl 2): 92-97.
50. Fossen A, Godlibsen OB, Loyning Y, Dreyfus JF. Effects of hypnotics on memory. Pharmacology 1983; 27(supplement 2): 116-26.
51. Subhan Z, Hindmarch I. Effects of zopiclone and benzodiazepine hypnotics on search in short-term memory. Neuropsychobiology 1984; 12: 244-48.
52. Broadhurst A, Cushnaghan RC. Residual effects of zopiclone (Imovane). Sleep 1987; 10(supplement 1): 48-53.
53. Billiard M, Besset A, de Lustrac C, Brissaud L. Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep 1987; 10(suppl 1): 27-34.
54. Nicholson AN, Stone BM. Efficacy of zopiclone in middle age. Sleep 1987; 10(suppl 1): 35-39.
55. Mizuki Y, Hirano H, Miyoshi A, et al. Residual effects of zopiclone on subsequent daytime functions in normal humans. Hum Psychopharmacol 1987; 2: 119-26.
56. Rettig HC, de Haan P, Zuurmond WWA, van Leeuwen L. Effects of hypnotics on sleep and psychomotor performance. A doubleblind randomised study of lormetazepam, midazolam and zopiclone. Anaesthesia 1990; 45: 1079-82.
57. Whitehead C, Sanders L, Appadurai I, Power I, Rosen M, Robinson J. Zopiclone as a preoperative night hypnotic: a doubleblind comparison with temazepam and placebo. Br J Anaesth 1994; 72: 443-446.
58. Tafti M, Besset A, Billiard M. Effects of zopiclone on subjective evaluation of sleep and daytime alertness and on psychomotor and physical performance tests in athletes. Prog Neuro-Psychopharm Biol-Psychiatry 1992; 16: 55-63.
59. Bocca ML, Denise P. Residual effects of hypnotics on disengagement of spatial attention. J Psychopharmacol 2000; 14: 401-5.
60. Grobler LA, Schwellnus MP, Trichard C, Calder S, Noakes TD, Derman WE. Comparative effects of zopiclone and loprazolam on psychomotor and physical performance in active individuals. Clin J Sport Med 2000; 10: 123-28.
61. Silva A, Collao A, Orellana M, Meléndez J, Caviedes P, Cárdenas AM. Zopiclone, but not brotizolam, impairs memory storage during sleep. Neurosci Res 2003, 47: 241-243.
62. Hemmeter U, Müller M, Bischof R, Annen B, Holsboer-Trachsler E. Effects of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology 2000, 147: 384-96.
63. Farber RH, Burke PJ. Post-bedtime dosing with indiplon in adults and the elderly: two placebo-controlled, active comparator crossover studies in healthy volunteers. Curr Med Res Opin 2008; 24: 837-46.
64. Dehlin O, Rundgren Å, Börjesson L, et al. Zopiclone to geriatric patients. A parallel double-blind dose-response clinical trial of zopiclone as a hypnotic to geriatric patients-a study in a geriatric hospital. Pharmacology 1983; 27(suppl 2): 173-78.
65. Klimm HD, Dreyfus JF, Delmotte M. Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 1987; 10(suppl 1): 73-78.
66. Malmelack M, Buck L, Csima A, Price V, Smiley A. Effects of flurazepam and zopiclone on the performance of chronic insomniac patients: a study of ethanol-drug interaction. Sleep 1987; 10(suppl 1): 79-87.
67. Tamminen T, Hanssen PP. Chronic administration of zopiclone and nitrazepam in the treatment of insomnia. Sleep 1987; 10(supplement 1): 63-72.
68. Ngen CC, Hassan R. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. Int Clin Psychopharmacol 1990; 5: 165-71.
69. Ponciano E, Freitas F, Camara J, Faria M, Barreto M, Hindmarch I. A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. Int Clin Psychopharmacol 1990; 5(suppl): 69-77.
70. Barbone F, McMahon AD, Davey PG et al. Association of road traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331-36.